• No results found

Effectiveness of hypoxia inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non dialysis dependent chronic kidney disease: a systematic review and meta analysis

N/A
N/A
Info
Download
Protected

Academic year: 2020

Share "Effectiveness of hypoxia inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non dialysis dependent chronic kidney disease: a systematic review and meta analysis"

Copied!
16
0
0

Loading.... (view fulltext now)

Download now ( 16 Page )

Full text

Figure

Figure 1 Flow chart of the identification of eligible studies. Initially 171 articles were searched from major databases, including 26 in PubMed, 72 in EMBASE and 73 in Web of Science
Table 2 The risk of bias of enrolled studies
Table 3 Summary of findings of roxadustat for renal anemia and AEs of chronic kidney disease (CKD) patients (patient or population: patients with anemia in CKD patients; settings: hospital; intervention: roxadustat)
Figure 2 Forest plots for comparisons of Δhemoglobin (Hb) and Hb response. In the analysis of ΔHb, data of 260 subjects were extracted
+7

References

Download now ( PDF - 16 Page - 3.50 MB )

Related documents